Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Laparoscopy × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 17 Colorectal Neoplasms 17 Colonic Neoplasms 16 Stomach Neoplasms 13 Gastrointestinal Stromal Tumors 4 Carcinoma, Hepatocellular 4 Pancreatic Neoplasms 3 Neoplastic Cells, Circulating 2 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Robotic 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Locally Advanced Pancreatic Adenocarcinoma 1 Locally Advanced Gastric Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Inflammatory Bowel Diseases 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Erectile Dysfunction 1 Diverticulum 1 Diverticulitis 1 Crohn Disease 1 Colorectal Liver Metastasis 1 Colonic Polyps 1 Colitis, Ulcerative 1

Interventions

Sorafenib 5 pembrolizumab 2 lenvatinib 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Immunotherapy 2 Blood Specimen Collection 2 Bevacizumab 2 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 sintilimab 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1 durvalumab 1 bavituximab 1 User-Centered Design 1 Sunitinib 1 Sufentanil 1 Ropivacaine 1 Ramucirumab 1 Radiotherapy 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01567631 2016-02-01

LAHIGA

Southwest Hospital, China

Phase NA Unknown

Gastrointestinal

Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡